Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous cord blood transfusion in preterm neonates
NCT02050971Phase 1Unknown
- Sponsor
- Pomeranian Medical University in Szczecin
- Start
- Oct 2010
- Primary completion
- Dec 2014
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of umbilical cord blood in neonatal anemia, intracranial hemorrhage (ICH), necrotizing enterocolitis (NEC) and 3 more (2 arms), sponsored by Pomeranian Medical University in Szczecin. Primary endpoint: Safety of autologous cord blood infusion at 1 year. Status: unknown.
02
Drugs
umbilical cord blood
03
Conditions
neonatal anemiaintracranial hemorrhage (ICH)necrotizing enterocolitis (NEC)respiratory distress syndrome (RDS)retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT02050971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02050971.